001     863112
005     20210130001829.0
024 7 _ |a 10.1007/978-3-319-98947-1_15
|2 doi
037 _ _ |a FZJ-2019-03215
041 _ _ |a English
100 1 _ |a Lewis, Jason S.
|0 P:(DE-HGF)0
|b 0
|e Editor
245 _ _ |a The Radiopharmaceutical Chemistry of Fluorine-18: Nucleophilic Fluorinations
260 _ _ |a Cham
|c 2019
|b Springer International Publishing
295 1 0 |a Radiopharmaceutical Chemistry / Lewis, Jason S. (Editor) , Chapter 15 ; ISBN: 978-3-319-98946-4 ; doi:10.1007/978-3-319-98947-1
300 _ _ |a 273-283
336 7 _ |a BOOK_CHAPTER
|2 ORCID
336 7 _ |a Book Section
|0 7
|2 EndNote
336 7 _ |a bookPart
|2 DRIVER
336 7 _ |a INBOOK
|2 BibTeX
336 7 _ |a Output Types/Book chapter
|2 DataCite
336 7 _ |a Contribution to a book
|b contb
|m contb
|0 PUB:(DE-HGF)7
|s 1560775936_19139
|2 PUB:(DE-HGF)
520 _ _ |a The positron-emitting radionuclide fluorine-18 plays a prominent role in radiopharmaceuticals for positron emission tomography (PET) due to its favourable nuclear decay properties. Depending on the production method, 18F can be obtained in two different chemical forms: electrophilic [18F]fluorine gas and nucleophilic [18F]fluoride. Nucleophilic [18F]fluoride exhibits several advantages with respect to accessibility and chemical handling. Therefore, nucleophilic 18F-substitution reactions are of pivotal importance for the production of PET radiotracers. This chapter is devoted to this class of reactions, and in the following pages, we seek to provide a general overview of 18F itself as well as insights into nucleophilic 18F-substitution reactions. More specifically, the prerequisites for this reaction with regard to solvent, leaving groups, reactants, etc. are examined. Furthermore, several examples are discussed which demonstrate the potential of this reaction to create highly clinical relevant PET tracers. Finally, this chapter also provides practical tips and tricks for those performing this reaction in the laboratory.
536 _ _ |a 573 - Neuroimaging (POF3-573)
|0 G:(DE-HGF)POF3-573
|c POF3-573
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef Book
700 1 _ |a Windhorst, Albert D.
|0 P:(DE-HGF)0
|b 1
|e Editor
700 1 _ |a Zeglis, Brian M.
|0 P:(DE-HGF)0
|b 2
|e Editor
700 1 _ |a Ermert, Johannes
|0 P:(DE-Juel1)131818
|b 3
|e Corresponding author
|u fzj
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 4
|u fzj
773 _ _ |a 10.1007/978-3-319-98947-1_15
909 C O |o oai:juser.fz-juelich.de:863112
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)131818
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)166419
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a contb
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21